Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1/2 1

Status

Unknown 6Completed 5Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 110Thoracic 6Head & Neck 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Radiation Injuries 1Non-small Cell Lung Cancer Stage â…¡ 1NSCLC 1Lung Neoplasms 1Advanced NSCLC With EGFR Mutation 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × S 1 (combination) × Thoracic × Clear all
NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Anhui Chest Hospital

Phase 2 Unknown
45 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Henan Cancer Hospital

Phase 2 Unknown
200 enrolled
Thoracic

Advanced NSCLC With EGFR Mutation

NCT04274270 2020-03-19

SBRTLCES

Peking University Third Hospital

Phase NA Unknown
60 enrolled
Thoracic

Lung Neoplasms, Radiation Injuries

NCT02631460 2015-12-16

S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC

Sun Yat-sen University

Phase 2 Unknown
470 enrolled
Thoracic

NSCLC

NCT02223611 2014-08-22

S1VSNP

Hebei Medical University Fourth Hospital

Phase 2 Unknown
100 enrolled
Thoracic

Non-small Cell Lung Cancer Stage â…¡

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 1/2 Unknown
74 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡